6.15
price down icon3.61%   -0.23
after-market Dopo l'orario di chiusura: 5.83 -0.32 -5.20%
loading

Cyclerion Therapeutics Inc Borsa (CYCN) Ultime notizie

pulisher
08:37 AM

CYCN stock is soaring 150% pre-market today — what is fueling the rally? - MSN

08:37 AM
pulisher
02:43 AM

CYCN PE Ratio & Valuation, Is CYCN Overvalued - Intellectia AI

02:43 AM
pulisher
Apr 04, 2026

If You Invested $1,000 in Cyclerion Therapeutics Inc (CYCN) - Stock Titan

Apr 04, 2026
pulisher
Apr 03, 2026

12 Health Care Stocks Moving In Thursday's Pre-Market Session - Sahm

Apr 03, 2026
pulisher
Apr 03, 2026

Globalstar, Exxon Mobil, Cyclerion Therapeutics, Eli Lilly And Intel: Why These 5 Stocks Are On Investors' Radars Today - Sahm

Apr 03, 2026
pulisher
Apr 03, 2026

SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Cyclerion Therapeutics, Inc. (NASDAQ: CYCN) - Sahm

Apr 03, 2026
pulisher
Apr 02, 2026

Korsana Biosciences and Cyclerion Therapeutics Announce All-Stock Merger and $380 Million Financing - Global Legal Chronicle

Apr 02, 2026
pulisher
Apr 02, 2026

Monteverde & Associates Investigates Cyclerion Therapeutics Merger - National Today

Apr 02, 2026
pulisher
Apr 02, 2026

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Cyclerion Therapeutics, Inc. (Nasdaq – CYCN), National Storage Affiliates (NYSENSA), Urgent.ly, Inc. (OTC MarketsULYX), UniFirst Corporation (NYSEU - ChartMill

Apr 02, 2026
pulisher
Apr 02, 2026

CYCN Plunges 17% After Merger Announcement: What’s Next for Cyclerion and Korsana? - Bitget

Apr 02, 2026
pulisher
Apr 02, 2026

Cyclerion and Korsana Tie the Knot with a New Merger Strategy - StocksToTrade

Apr 02, 2026
pulisher
Apr 02, 2026

Cyclerion Therapeutics Merger Sparks Investor Uncertainty - timothysykes.com

Apr 02, 2026
pulisher
Apr 02, 2026

Penny Stock CYCN Surged More Than 300% Yesterday. Why, And Should You Chase the Rally Here? - inkl

Apr 02, 2026
pulisher
Apr 02, 2026

Korsana boosts Alzheimer’s work with reverse merger, $380M financing - BioWorld MedTech

Apr 02, 2026
pulisher
Apr 02, 2026

Cyclerion Therapeutics and Korsana Biosciences Announce $380M Merger to Advance Alzheimer’s Treatment KRSA-028 - Minichart

Apr 02, 2026
pulisher
Apr 02, 2026

CYCN Earnings History & Surprises | EPS & Revenue Results | CYCLERION THERAPEUTICS INC (NASDAQ:CYCN) - ChartMill

Apr 02, 2026
pulisher
Apr 02, 2026

12 Health Care Stocks Moving In Wednesday's Intraday Session - Sahm

Apr 02, 2026
pulisher
Apr 02, 2026

CYCN Stock Alert: Halper Sadeh LLC is Investigating Whether Cyclerion Therapeutics, Inc. is Obtaining a Fair Price for its Shareholders - The Joplin Globe

Apr 02, 2026
pulisher
Apr 01, 2026

Cyclerion Therapeutics, Inc. (CYCN) stock price, news, quote and history - Yahoo Finance UK

Apr 01, 2026
pulisher
Apr 01, 2026

Cyclerion Therapeutics Merges with Korsana Biosciences in New Agreement - El-Balad.com

Apr 01, 2026
pulisher
Apr 01, 2026

Korsana takes its brain shuttle tech public via reverse merger with Cyclerion - FirstWord Pharma

Apr 01, 2026
pulisher
Apr 01, 2026

Shareholder Alert: Ademi LLP investigates whether Cyclerion Therapeutics Inc. is obtaining a Fair Price for Public Shareholders - PR Newswire

Apr 01, 2026
pulisher
Apr 01, 2026

Korsana Biosciences and Cyclerion Therapeutics to Merge, Operate Under Korsana Name - Contract Pharma

Apr 01, 2026
pulisher
Apr 01, 2026

Cyclerion Therapeutics to Merge with Korsana Biosciences - TipRanks

Apr 01, 2026
pulisher
Apr 01, 2026

Cyclerion Therapeutics: $380 Million Financing To Merge With Korsana Biosciences And Advance Alzheimer’s Pipeline - pulse2.com

Apr 01, 2026
pulisher
Apr 01, 2026

Cyclerion Therapeutics (NASDAQ: CYCN) to merge with Korsana, $380M PIPE backing - Stock Titan

Apr 01, 2026
pulisher
Apr 01, 2026

Cyclerion to Merge With Korsana; $380 Million PIPE, CVRs and Lock-Ups Support Deal - TradingView

Apr 01, 2026
pulisher
Apr 01, 2026

Korsana Biosciences to go public via Cyclerion (CYCN) reverse merger and $380M PIPE - Stock Titan

Apr 01, 2026
pulisher
Apr 01, 2026

Korsana Taps Cyclerion For $380M Public Listing In Boston - Hoodline

Apr 01, 2026
pulisher
Apr 01, 2026

Best Pharmaceutical Stocks To Follow NowApril 1st - MarketBeat

Apr 01, 2026
pulisher
Apr 01, 2026

Promising Medical Stocks To ConsiderApril 1st - MarketBeat

Apr 01, 2026
pulisher
Apr 01, 2026

Cyclerion Therapeutics stock soars 350% on Korsana merger, $380 million financing - MSN

Apr 01, 2026
pulisher
Apr 01, 2026

Cyclerion provides public listing vehicle for Korsana in $380M deal - The Business Journals

Apr 01, 2026
pulisher
Apr 01, 2026

Cyclerion Therapeutics, Inc. (CYCN) Stock: Skyrockets 324% on Blockbuster Korsana Merger Backed by Wall Street's Biggest Names - parameter.io

Apr 01, 2026
pulisher
Apr 01, 2026

CYCN Stock Explodes 313% on April 1 After Cyclerion-Korsana Merger Deal for Alzheimer's Pipeline - International Business Times Australia

Apr 01, 2026
pulisher
Apr 01, 2026

Crude Oil Down Over 1%; ISM Manufacturing PMI Rises In March - Benzinga

Apr 01, 2026
pulisher
Apr 01, 2026

Why is Biotech Stock Cyclerion Therapeutics, Inc. (Nasdaq: CYCN) Gaining? - Investorideas.com

Apr 01, 2026
pulisher
Apr 01, 2026

Cyclerion Therapeutics, Korsana Biosciences enter merger agreement - tipranks.com

Apr 01, 2026
pulisher
Apr 01, 2026

Cyclerion Therapeutics and Korsana Biosciences Announce Merger Agreement - Business Wire

Apr 01, 2026
pulisher
Apr 01, 2026

Cyclerion Therapeutics (CYCN) Stock Jumps 160% Following Korsana Biosciences Merger Announcement - MEXC Exchange

Apr 01, 2026
pulisher
Apr 01, 2026

Trending Stocks Today | Cyclerion Therapeutics Shoots up 322.9% - Moomoo

Apr 01, 2026
pulisher
Apr 01, 2026

Cyclerion Therapeutics and Korsana Biosciences To Merge - citybiz

Apr 01, 2026
pulisher
Apr 01, 2026

Cyclerion Therapeutics Stock Soars 350% On Korsana Merger, $380 Million Financing - Benzinga

Apr 01, 2026
pulisher
Apr 01, 2026

Cyclerion Therapeutics surges as it agrees to merge with Korsana Biosciences in a deal backed by a large private financing - Quiver Quantitative

Apr 01, 2026
pulisher
Apr 01, 2026

Dow Jumps Over 200 Points; Nike Shares Tumble After Q3 Results - Benzinga

Apr 01, 2026
pulisher
Apr 01, 2026

Cyclerion Therapeutics (CYCN) Stock Surges 160% on Korsana Merger Deal - MEXC

Apr 01, 2026
pulisher
Apr 01, 2026

Financial Uncertainty Looms as CYCN Faces Market Changes - StocksToTrade

Apr 01, 2026
pulisher
Apr 01, 2026

Alzheimer's-focused Korsana uses Cyclerion merger to go public - Fierce Biotech

Apr 01, 2026
pulisher
Apr 01, 2026

$Cyclerion Therapeutics (CYCN.US)$ 🥳 - Moomoo

Apr 01, 2026
pulisher
Apr 01, 2026

Cyclerion Therapeutics and Korsana Biosciences to merge - The Pharma Letter

Apr 01, 2026
pulisher
Apr 01, 2026

CYCN Stock Is Soaring 274% Today — What Is Fueling The Rally? - Stocktwits

Apr 01, 2026
pulisher
Apr 01, 2026

Cyclerion Therapeutics (CYCN) Skyrockets 160% Following Korsana Biosciences Merger Announcement - parameter.io

Apr 01, 2026
pulisher
Apr 01, 2026

CYCN Merges with Korsana Biosciences for Strategic Growth - GuruFocus

Apr 01, 2026
pulisher
Apr 01, 2026

Cyclerion Stock Rallies As Research Venture Promises Bright Future - timothysykes.com

Apr 01, 2026
pulisher
Apr 01, 2026

Cyclerion Therapeutics (CYCN) Shares Jump 160% Following Korsana Biosciences Merger Agreement - MoneyCheck

Apr 01, 2026
pulisher
Apr 01, 2026

$Cyclerion Therapeutics (CYCN.US)$ good day! - Moomoo

Apr 01, 2026
pulisher
Apr 01, 2026

$Cyclerion Therapeutics (CYCN.US)$ ok enough 🥳 - Moomoo

Apr 01, 2026
pulisher
Apr 01, 2026

Cyclerion Soars Over 160% After Announcing Merger With Korsana Biosciences - rttnews.com

Apr 01, 2026
pulisher
Apr 01, 2026

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Apr 01, 2026
pulisher
Apr 01, 2026

Why is Cyclerion Therapeutics Stock (CYCN) Up Over 160% Today? - TipRanks

Apr 01, 2026
pulisher
Apr 01, 2026

Cyclerion to merge with Korsana in $380 million deal - Investing.com

Apr 01, 2026
$99.12
price up icon 0.49%
$28.33
price up icon 1.76%
$48.57
price up icon 0.16%
$91.18
price up icon 1.97%
ONC ONC
$310.79
price up icon 0.76%
$162.43
price down icon 1.47%
Capitalizzazione:     |  Volume (24 ore):